In melanoma patients treated with anti-PD-1 antibodies, peripheral CD8+ T cells were proliferative and showed co-expression of PD-1 and CTLA-4 at day 7 after treatment, but only in responsive patients (159–161). The gene discussed is CTLA4; the disease is melanoma.